CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cobra Biologics Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cobra Biologics Holdings Ltd
Stephenson Building, The Science Park
Phone: +44 1782714181p:+44 1782714181 KEELE, ST5 5SP  United Kingdom Fax: +44 1782714168f:+44 1782714168
This is a Subsidiary, click here for the Parent Company
Business Summary
Cobra Biologics Holdings Ltd. is a holding company which operates as an international provider of contract manufacturing services for the global biopharmaceutical industry. The principal activity of the Company is the provision of manufacturing services for protein, virus and deoxyribonucleic acid (DNA)-based pharmaceuticals. The Company’s business segments are Protein, Virus, DNA and Cell Line. It operates two United Kingdom-based manufacturing facilities, one located in Keele, Staffordshire, and the other in Cowley, Oxfordshire, both of which trade through the Company’s wholly owned trading subsidiary, Cobra Biologics Limited. The Company’s other subsidiaries are Cobra Oral Technology Limited, whose principal activity will be to develop the oral vaccine platform technology, ORT-VAC; Cobra Biomanufacturing EBT Limited, whose principal activity is to act as trustee to the Company’s long term incentive plan, and Cobra Biomanufacturing LLC, which is dormant.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201812/31/2018Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Daniel R.Chapchal 68 8/21/2009 8/21/2009
Chief Executive, Executive Director SimonSaxby 54 6/1/2008 1/8/2008
Finance Director, Company Secretary, Executive Director Peter A.Coleman 51 6/1/2002
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 123 (As of 9/30/2008)
Outstanding Shares: 44,339,000 (As of 12/31/2018)
Shareholders: 485
Stock Exchange: SEA
Fax Number: +44 1782714168


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023